Home
About
Overview
Sharing Data
ORCID
Help
History (1)
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma.
It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma. J Clin Oncol. 2017 02; 35(4):475-477.
View in:
PubMed
subject areas
Adenocarcinoma
Cetuximab
Epirubicin
Esophageal Neoplasms
Esophagogastric Junction
Humans
Stomach Neoplasms